Radiogenomics prediction for MYCN amplification in neuroblastoma: A hypothesis generating study.
Angela Di GiannatalePier Luigi Di PaoloDavide CurioneJacopo LenkowiczAntonio NapolitanoAurelio SecinaroPaolo TomaFranco LocatelliAurora CastellanoLuca BoldriniPublished in: Pediatric blood & cancer (2021)
CT-based radiomics is able to predict MYCN amplification status in NB, paving the way to the in-depth analysis of imaging based biomarkers that could enhance outcomes prediction.